Stay updated on Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page footer now shows Revision: v3.5.5, replacing the previous v3.5.4, indicating a small update to the page rendering.
    Difference
    0.0%
    Check dated 2026-06-08T04:11:50.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.3 to v3.5.4, indicating a deployed update to the ClinicalTrials.gov entry.
    Difference
    0.0%
    Check dated 2026-05-17T10:18:08.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page’s footer revision label has been updated from v3.5.2 to v3.5.3, reflecting a site software/version change rather than a change to the clinical trial record.
    Difference
    0.0%
    Check dated 2026-04-25T18:40:01.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:24:13.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Adrenal cortex carcinoma was added as a lay term for Adrenocortical Carcinoma in the Conditions section.
    Difference
    0.0%
    Check dated 2026-03-27T21:52:33.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-20T19:36:23.000Z thumbnail image

Stay in the know with updates to Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page.